Antiretroviral Formulations
A comparative list of antiretroviral drug formulations by class (NNRTIs, NRTIs, protease inhibitors, entry/fusion inhibitors, integrase inhibitors, PK enhancer, fixed-dose combination) for HIV-1 infection.
HIV/AIDS
Impact of Diet Among Patients With HIV at Risk for Antiretroviral Therapy-Associated Weight Gain
Investigators conducted a study to determine the effects of antiretroviral therapy on weight gain in patients with HIV infection.
Prevalence of Noncalcified Coronary Plaques and CAC in People Living With HIV
This meta-analysis examined the burden of subclinical CV disease in people living with HIV.
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in African American Adults With HIV Infection
Researchers conducted a study to assess virologic outcomes and adherence associated with treatment with bictegravir/emtricitabine/tenofovir alafenamide in African American patients with HIV infection.
Efficacy of First-Line Treatment With Dolutegravir/Lamivudine in Patients With Newly Diagnosed HIV Infection
Investigators conducted a secondary analysis that assessed virologic outcomes following 48 weeks of first-line treatment with dolutegravir/lamivudine in patients with newly diagnosed HIV infection.
Effects of Ritonavir-Boosted Darunavir vs Doravirine in Patients With HIV Infection
Researchers conducted a study that compared virologic suppression, lipid control, and safety profiles of patients with HIV infection who switch from ritonavir-boosted darunavir to doravirine (DOR) therapy vs those who continued DOR therapy.
Two-Drug Regimen Increases Risk for Virologic Failure in Individuals With HIV Infection
Researchers conducted a study that included patients with HIV infection who previously achieved virologic suppression to compare the risk for virologic failure among those who switch to a single-tablet 2-drug regimen vs those who switch to a single-tablet 3-drug regimen.
Risk for Hypertriglyceridemia in Patients With HIV Infection Treated With Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy
Researchers conducted a study to determine whether integrase strand transfer inhibitor-based antiretroviral therapy is associated with lipid changes in patients with HIV infection.
Efficacy of Long-Acting Cabotegravir Plus Rilpivirine in Patients With HIV Coinfected With Asymptomatic Hepatitis C
Researchers sought to determine the safety and efficacy of treatment with long-acting cabotegravir plus rilpivirine in patients with HIV coinfected with asymptomatic hepatitis c virus.
Increased Persistence, Re-Initiation of HIV Pre-Exposure Prophylaxis Found Among Patients Treated With Emtricitabine/Tenofovir Alafenamide
Investigators conducted a study that compared the rate of persistence and re-initiation of HIV pre-exposure prophylaxis among patients treated with emtricitabine/tenofovir alafenamide vs those treated with emtricitabine/tenofovir disoproxil fumarate.
- Loading...
Loading...
Next post in IDWeek 2021 HIV In-depth
Loading... 
Loading...